Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 29

The Research Roundup provides an overview of the past week’s research from Mayo Medical Laboratories consultants, including featured abstracts and complete list of published studies and reviews.

Featured Abstract

Individualized Approaches are Needed for Optimized Blood Cultures

Communique-062015-BloodCells[1]Many strategies and technologies are available that strive to improve blood culture (BC)-based diagnostics. The ideal approach to BCs varies between health care institutions. Institutions need to examine clinical needs and practices in order to optimize BC-based diagnostics for their site. Before laboratories consider offering rapid MALDI-ToF MS or expensive rapid panel-based molecular BC diagnostics, they should optimize pre-analytical, analytical and post-analytical processes and procedures surrounding BC systems. Several factors need to be considered, including local resistance rates, antibiotic prescribing patterns, patient- and provider-types, laboratory staffing, and personnel available to liaise with clinicians to optimize antibiotic use. While there is much excitement surrounding new high-technology diagnostics, cost-neutral benefits can be realized by optimizing existing strategies and using available tools in creative ways. Implementation of rapid BC diagnostics should be done in a manner that optimizes impact. Strategies to optimize these BC diagnostics in individual laboratories are presented. The statement was published in Clinical Infectious Diseases.

Published to PubMed This Week



Brent Westra is a Marketing Segment Manager at Mayo Clinic Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.